| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | M | 400 | $0.00 | $0.00 | View Details Filing |
| Sep 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | M | 400 | $14.50 | $5,800.00 | View Details Filing |
| Sep 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 400 | $90.00 | $36,000.00 | View Details Filing |
| Sep 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 4,845 | $86.40 | $418,608.00 | View Details Filing |
| Sep 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 16,548 | $87.20 | $1,442,985.60 | View Details Filing |
| Sep 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | M | 27,999 | $0.00 | $0.00 | View Details Filing |
| Sep 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 400 | $89.38 | $35,752.00 | View Details Filing |
| Sep 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 6,206 | $88.17 | $547,183.02 | View Details Filing |
| Sep 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | M | 27,999 | $14.50 | $405,985.50 | View Details Filing |
1 more transactions available โ create a free account to see 12 months of history | ||||||